|
|
|
 |
FDA Approval Activities for this Drug…
PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.125MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.25MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.5MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 1.5MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 1MG MIRAPEX PHARMACIA AND UPJOHN | MIRAPEX (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim, New or Modified Indication | Pramipexole Dihydrochloride Tablets, Barr Labs, Tentative Approval | Pramipexole Dihydrochloride Tablets, Barr Labs, Approval | Mirapex (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Pramipexole Dihydrochloride Tablets, Alembic, Ltd., Tentative Approval | Pramipexole Dihydrochloride Tablets, Glenmark Generics Limited, Tentative Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Approval | Pramipexole Dihydrochloride Tablets, Sandoz, Inc., Tentative Approval | Pramipexole Dihydrochloride Tablets, Mylan Pharmaceuticals, Inc., Approval | Pramipexole Dihydrochloride Tablets, Torrent Pharmaceuticals, Tentative Approval | Pramipexole Dihydrochloride Tablets, Zydus Pharmaceuticals, Tentative Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Pramipexole Dihydrochloride Tablets, Zydus Pharmaceuticals, Approval | Pramipexole Dihydrochloride Tablets, Sandoz Inc., Approval | Pramipexole Dihydrochloride Tablets, Sandoz, Inc., Approval | Pramipexole Dihydrochloride Tablets, Actavis Pharma Manufacturing, Approval | Mirapex (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Efficacy Supplement
  
|